Development and characterisation of glucosamine sulphate magnetic nanoparticles for rheumatoid arthritis chemotherapy. (1st November 2020)

• Record Type: Journal Article
• Authors: Subbiah, Latha; Palanisamy, Selvamani; Thimiri Govinda Raj, Deepak B.
• Is Part Of: Micro & nano letters. Volume 15:Number 13(2020)
• Page Start: 954
• Page End: 958
• Publication Date: 2020-11-01
• Subjects: patient treatment -- nanoparticles -- drugs -- magnetic particles -- diseases -- nanomedicine -- cellular biophysics -- biomedical materials -- cancer -- molecular biophysics -- biochemistry -- drug delivery systems; glucosamine sulphate magnetic nanoparticles -- rheumatoid arthritis chemotherapy -- autoimmune disease -- synovial joints -- associated regions -- targetted drug delivery -- anti‐rheumatic drugs -- magnetically targetted RA chemotherapy; Nanotechnology -- Periodicals; Nanostructures -- Periodicals; Microtechnology -- Periodicals; 620.5
• DOI: 10.1049/mnl.2019.0748
• Languages: English
• ISSNs: 1750-0443

Abstract

Abstract : Rheumatoid arthritis (RA) is an autoimmune disease that principally attacks synovial joints. RA also cause inflammation in the joints and associated regions. There is an unmet medical need for RA as well as for the targetted drug delivery of anti‐rheumatic drugs to improve its efficacy at a much lower doses while decreasing its side effects. Hence, in this Letter, the authors report the development and characterisation of glucosamine sulphate magnetic nanoparticles for magnetically targetted RA chemotherapy.